[Experimental evaluation of the new cephalosporin antibiotic cephacetrile].
D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use; D000667:Ampicillin / Q000494:pharmacology; D000818:Animals; D002509:Cephaloridine / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology* / Q000627:therapeutic use; D002512:Cephalothin / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004926:Escherichia coli / Q000187:drug effects; D005839:Gentamicins / Q000494:pharmacology; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D051379:Mice; D008826:Microbial Sensitivity Tests; D009345:Neisseria meningitidis / Q000187:drug effects; D009570:Nitriles / Q000627:therapeutic use; D011511:Proteus / Q000187:drug effects; D011513:Proteus mirabilis / Q000187:drug effects; D051381:Rats; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012475:Salmonella / Q000187:drug effects; D012760:Shigella / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy
D000081:Acetamides; D002511:Cephalosporins; D005839:Gentamicins; D009570:Nitriles; D000667:Ampicillin; D002509:Cephaloridine; D002512:Cephalothin
Experimentelle Auswertung des neuen Cephalosporin-Antibiotikums Cephacetril